189 related articles for article (PubMed ID: 12595261)
1. Crystal structures of Aspergillus oryzae aspartic proteinase and its complex with an inhibitor pepstatin at 1.9A resolution.
Kamitori S; Ohtaki A; Ino H; Takeuchi M
J Mol Biol; 2003 Mar; 326(5):1503-11. PubMed ID: 12595261
[TBL] [Abstract][Full Text] [Related]
2. Structure of the Rhizomucor miehei aspartic proteinase complexed with the inhibitor pepstatin A at 2.7 A resolution.
Yang J; Quail JW
Acta Crystallogr D Biol Crystallogr; 1999 Mar; 55(Pt 3):625-30. PubMed ID: 10089458
[TBL] [Abstract][Full Text] [Related]
3. Statistical coupling analysis of aspartic proteinases based on crystal structures of the Trichoderma reesei enzyme and its complex with pepstatin A.
Nascimento AS; Krauchenco S; Golubev AM; Gustchina A; Wlodawer A; Polikarpov I
J Mol Biol; 2008 Oct; 382(3):763-78. PubMed ID: 18675276
[TBL] [Abstract][Full Text] [Related]
4. X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.
Bailey D; Cooper JB; Veerapandian B; Blundell TL; Atrash B; Jones DM; Szelke M
Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):363-71. PubMed ID: 8424781
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin.
Fujimoto Z; Fujii Y; Kaneko S; Kobayashi H; Mizuno H
J Mol Biol; 2004 Aug; 341(5):1227-35. PubMed ID: 15321718
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of human pepsin and its complex with pepstatin.
Fujinaga M; Chernaia MM; Tarasova NI; Mosimann SC; James MN
Protein Sci; 1995 May; 4(5):960-72. PubMed ID: 7663352
[TBL] [Abstract][Full Text] [Related]
7. Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors.
Suguna K; Padlan EA; Bott R; Boger J; Parris KD; Davies DR
Proteins; 1992 Jul; 13(3):195-205. PubMed ID: 1603809
[TBL] [Abstract][Full Text] [Related]
8. Replacement of isobutyl by trifluoromethyl in pepstatin A selectively affects inhibition of aspartic proteinases.
Binkert C; Frigerio M; Jones A; Meyer S; Pesenti C; Prade L; Viani F; Zanda M
Chembiochem; 2006 Jan; 7(1):181-6. PubMed ID: 16307463
[TBL] [Abstract][Full Text] [Related]
9. Comparative modelling and analysis of amino acid substitutions suggests that the family of pregnancy-associated glycoproteins includes both active and inactive aspartic proteinases.
Guruprasad K; Blundell TL; Xie S; Green J; Szafranska B; Nagel RJ; McDowell K; Baker CB; Roberts RM
Protein Eng; 1996 Oct; 9(10):849-56. PubMed ID: 8931124
[TBL] [Abstract][Full Text] [Related]
10. The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A.
Borelli C; Ruge E; Schaller M; Monod M; Korting HC; Huber R; Maskos K
Proteins; 2007 Aug; 68(3):738-48. PubMed ID: 17510964
[TBL] [Abstract][Full Text] [Related]
11. X-ray analyses of aspartic proteinases. III Three-dimensional structure of endothiapepsin complexed with a transition-state isostere inhibitor of renin at 1.6 A resolution.
Veerapandian B; Cooper JB; Sali A; Blundell TL
J Mol Biol; 1990 Dec; 216(4):1017-29. PubMed ID: 2266553
[TBL] [Abstract][Full Text] [Related]
12. Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin.
James MN; Sielecki A; Salituro F; Rich DH; Hofmann T
Proc Natl Acad Sci U S A; 1982 Oct; 79(20):6137-41. PubMed ID: 6755464
[TBL] [Abstract][Full Text] [Related]
13. The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors.
Cutfield SM; Dodson EJ; Anderson BF; Moody PC; Marshall CJ; Sullivan PA; Cutfield JF
Structure; 1995 Nov; 3(11):1261-71. PubMed ID: 8591036
[TBL] [Abstract][Full Text] [Related]
14. Crystallization of inhibited aspartic proteinase from Candida albicans.
Cutfield S; Marshall C; Moody P; Sullivan P; Cutfield J
J Mol Biol; 1993 Dec; 234(4):1266-9. PubMed ID: 8263928
[TBL] [Abstract][Full Text] [Related]
15. Subsite preferences of pepstatin-insensitive carboxyl proteinases from prokaryotes: kumamolysin, a thermostable pepstatin-insensitive carboxyl proteinase.
Oda K; Ogasawara S; Oyama H; Dunn BM
J Biochem; 2000 Sep; 128(3):499-507. PubMed ID: 10965051
[TBL] [Abstract][Full Text] [Related]
16. Kinetic and mechanistic analysis of the association and dissociation of inhibitors interacting with secreted aspartic acid proteases 1 and 2 from Candida albicans.
Backman D; Danielson UH
Biochim Biophys Acta; 2003 Mar; 1646(1-2):184-95. PubMed ID: 12637026
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 1,4-beta-D-xylan xylanohydrolase by the specific aspartic protease inhibitor pepstatin: probing the two-step inhibition mechanism.
Vathipadiekal V; Rao M
J Biol Chem; 2004 Nov; 279(45):47024-33. PubMed ID: 15317808
[TBL] [Abstract][Full Text] [Related]
18. Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution.
Fitzgerald PM; McKeever BM; VanMiddlesworth JF; Springer JP; Heimbach JC; Leu CT; Herber WK; Dixon RA; Darke PL
J Biol Chem; 1990 Aug; 265(24):14209-19. PubMed ID: 2201682
[TBL] [Abstract][Full Text] [Related]
19. Structure of human uropepsin at 2.45 A resolution.
Canduri F; Teodoro LG; Fadel V; Lorenzi CC; Hial V; Gomes RA; Neto JR; de Azevedo WF
Acta Crystallogr D Biol Crystallogr; 2001 Nov; 57(Pt 11):1560-70. PubMed ID: 11679720
[TBL] [Abstract][Full Text] [Related]
20. A neutron Laue diffraction study of endothiapepsin: implications for the aspartic proteinase mechanism.
Coates L; Erskine PT; Wood SP; Myles DA; Cooper JB
Biochemistry; 2001 Nov; 40(44):13149-57. PubMed ID: 11683623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
